In research, this combination in one vial offers clear advantages: Perfect synergy between the two substances Easy handling within research setups Short-acting effect without long-term hormonal stress Consistent ratio of Ipamorelin to CJC-1295 Packaging & storage Contents: 1 vial of Ipamorelin 5 mg + CJC-1295 no DAC 5 mg Storage: Store cool and dry (2-8 C), protected from light Why choose this combined peptide
The FDAs removal of long-standing black box warnings on hormone therapy products triggered a prescription surge and supply shortage
While GLP-1 receptor agonists have a relatively wide safety margin, exceeding recommended doses or escalating too quickly can trigger severe adverse effects including acute pancreatitis, severe dehydration, and gastrointestinal damage
Athletes subject to drug testing should not use ipamorelin
Loading with enzalutamide produces a much larger total mass loss (50% up to 800 C), indicating a substantial organic fraction attributable to the drug
12 weeks (1x daily, 5-on/2-off) 4 vials 60 doses needed (5x12)
